← Back
Data updated: Mar 10, 2026
ZHEJIANG JIUZHOU
Neurology
ZHEJIANG JIUZHOU is a generic drug manufacturer focused on Neurology.
2022
Since
1
Drugs
-
Trials
16
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CARBAMAZEPINE 2026-01-05
Labeling
CARBAMAZEPINE 2025-08-15
Labeling
CARBAMAZEPINE 2025-07-25
CARBAMAZEPINE 2025-07-01
Labeling
CARBAMAZEPINE 2025-06-23
Labeling
CARBAMAZEPINE 2025-04-16
CARBAMAZEPINE 2025-01-27
Labeling
CARBAMAZEPINE 2025-01-27
Labeling
CARBAMAZEPINE 2025-01-27
Labeling
CARBAMAZEPINE 2025-01-16
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-03-31
- Latest
- 2025-08-15
- Applications
- 1